US Supreme Court ruling resets Trump's tariff regime.
Eucalyptus sells to US healthcare giant Hims & Hers for USD1.15b.
Firmus’ sustainability claims are evolving as rapidly as AI sector advances at warp speed.
Superpower is being sued by US rival for operating with ‘flippant disregard’.
Firmus nabbed some big name backing, but not everyone is convinced.
Top six US bank bosses each earned at least USD40m in 2025.
Pro Medicus CEO is utterly stumped by $16b share price rout.
Anthropic quietly begins a low-key charm offensive downunder.
EVP lodges $750,000 with court to keep Strong Room claims alive.
Challenger's Pepper Money deal stokes share buyback concerns.
Wall St bounced, but Goldman sees more downside ahead.
Market baulks at Maas Group’s radical AI pivot.
